Concerns over leaks compelled the top US infectious disease official to reveal data on Gilead Sciences experimental drug remdesivir, the first in a scientifically rigorous clinical trial to show benefit in treating COVID-19.
At brunch next time, pass on the coffee cake and have an omelette